rawfin.tv
Artelo Biosciences Terminates ATM Offering, Adjusts Financing Approach
MarketsstocksAI Generated

Artelo Biosciences Terminates ATM Offering, Adjusts Financing Approach

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Artelo Biosciences (ARTL) has announced the termination of its at-the-market (ATM) equity offering agreement with R.F. Lafferty. This move signals a shift in the company's financing strategy, effective immediately.

biotechnologyequity offeringcorporate financestock market

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks